-
Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod
2026-06-22
This study elucidates how metabolic dysfunction, specifically in high-fat/high-cholesterol diet-induced MASH mice, significantly alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids. The findings underscore the importance of disease state–specific dosing and transporter/enzyme expression monitoring in optimizing therapeutic strategies for MASH.
-
Busulfan: DNA Alkylating Agent for Senescence and Germ Cell
2026-06-22
Busulfan is a gold-standard DNA alkylating agent enabling precise senescence induction in human fibroblasts and robust germ cell depletion in mice. This guide unpacks stepwise protocols, troubleshooting strategies, and cutting-edge lineage tracing use-cases, helping researchers maximize reproducibility and interpretability in cellular and in vivo studies.
-
Protein A/G Magnetic Co-IP/IP Kit: Advancing Mitochondrial D
2026-06-21
Discover how the Protein A/G Magnetic Co-IP/IP Kit empowers co-immunoprecipitation of protein complexes and protein-protein interaction analysis in mitochondrial dysfunction studies. Explore innovative assay design and the latest scientific insights for translational research.
-
TMEM16F in Kupffer Cells Shields Liver from Listeria Damage
2026-06-20
This study uncovers how TMEM16F, a calcium-activated lipid scramblase, expressed in liver Kupffer cells, protects against Listeria monocytogenes infection by preventing cell death and excessive inflammation. The findings redefine the cellular mechanisms safeguarding hepatic tissue during bacterial challenge, with implications for research in programmed cell death and inflammatory liver disorders.
-
Forsythoside E (SKU N2883): Reliable PKM2 Inhibitor for Macr
2026-06-19
This article provides a scenario-driven, evidence-based guide for biomedical researchers evaluating Forsythoside E (SKU N2883) as a pyruvate kinase M2 (PKM2) inhibitor in cell viability and immunometabolic assays. Drawing on validated quantitative data, it explores Forsythoside E's unique mechanisms, protocol parameters, and practical selection strategies for reproducible macrophage research.
-
SP2509 in Cancer Epigenetics: A Mechanistic and Translationa
2026-06-19
Explore how SP2509, a potent Lysine-specific demethylase 1 antagonist, advances cancer epigenetics research with precise mechanistic action and translational relevance. This article offers a unique, in-depth perspective not found in existing protocol-focused content.
-
Tyrothricin Peptide Antibiotic Mixture: Applied Antimicrobia
2026-06-18
Tyrothricin’s unique membrane-disruptive profile streamlines infection modeling and membrane biology research across bacteria, fungi, and select viruses. Learn how its precise protocol parameters and troubleshooting insights enable reproducible, cross-domain experimental success.
-
Novel Phenylethanoid Glycosides from Forsythia suspensa: Iso
2026-06-18
The reference study reports the isolation and structural elucidation of three new caffeoyl phenylethanoid glycosides (Forsythosides H-J) and six known glycosides, including Forsythoside E, from the fruits of Forsythia suspensa. This work advances the chemical profiling of Forsythia-derived compounds and supports their ongoing evaluation in inflammation and immunometabolism research.
-
Disulfiram in Cancer Research: Synthetic Lethality and Beyon
2026-06-17
This thought-leadership article explores how Disulfiram, a legacy dopamine β-hydroxylase inhibitor and copper-binding agent, is redefining paradigms in translational cancer research. Integrating recent discoveries in synthetic lethality—particularly in APC-deficient colorectal cancer—alongside its established roles in proteasomal chymotrypsin-like activity inhibition and apoptotic cancer cell death induction, we deliver mechanistic insights and actionable guidance. Readers will find evidence-based protocol parameters, a comparison with emerging competitors, and a visionary outlook for experimental design, all grounded in cited studies and the unique advantages of APExBIO's Disulfiram.
-
BODIPY 581/591 C11: Advanced Ratiometric Probing of Lipid Pe
2026-06-17
Explore how the ratiometric fluorescent probe BODIPY 581/591 C11 enables unprecedented, quantitative insight into lipid peroxidation and antioxidant capacity in live-cell models. This article uncovers advanced assay strategies and integrates new findings on endothelial ferroptosis, setting it apart from existing resources.
-
Remdesivir (GS-5734): Optimizing Antiviral Workflows for RNA
2026-06-16
Remdesivir (GS-5734) stands out as a potent, benchmark antiviral for translational research targeting RNA viruses such as coronaviruses and filoviruses. This guide outlines practical protocols, advanced applications, and troubleshooting strategies, leveraging structural insights to maximize experimental reproducibility and efficacy.
-
NHS-Biotin in Protein Labeling: Precision Workflows & Innova
2026-06-16
NHS-Biotin enables rapid, stable, and site-specific biotinylation of proteins even in complex intracellular environments. Recent advances showcase its unmatched performance for multimeric protein engineering and high-sensitivity detection workflows, positioning APExBIO’s NHS-Biotin as the reagent of choice for demanding biochemical research.
-
Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp
2026-06-15
The Protein A/G Magnetic Co-IP/IP Kit streamlines co-immunoprecipitation of protein complexes with rapid, high-specificity capture and minimal degradation. Optimized for sensitive protein-protein interaction analysis and antibody purification, this APExBIO solution empowers reproducible workflows from bench to proteomics readout.
-
Live-Dead Cell Staining Kit: Precision Viability with Calcei
2026-06-15
The Live-Dead Cell Staining Kit empowers researchers to distinguish viable from non-viable cells with enhanced precision using dual Calcein-AM and Propidium Iodide fluorescence. Its robust, streamlined protocol adapts seamlessly to flow cytometry, microscopy, and advanced drug cytotoxicity workflows—surpassing traditional viability assays in both accuracy and interpretability.
-
Bafilomycin A1: Strategic V-ATPase Inhibition for Translatio
2026-06-14
Explore how Bafilomycin A1, a potent V-ATPase inhibitor, is shaping mechanistic insight and translational strategy in cell biology and cancer research. This article integrates new evidence on lysosomal pH regulation, double-positive feedback in metabolic stress, and the evolving competitive landscape, offering actionable guidance for advanced experimental workflows.